Company Performance: JANX.US's revenue, earnings, and profitability directly influence investor confidence. Strong financials typically lead to higher stock prices.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry, especially the specific therapeutic areas JANX.US targets, impact its stock value.

Regulatory Environment: Changes in FDA regulations, approval processes, and drug pricing policies can significantly affect JANX.US's future profitability and stock price.

Clinical Trial Results: Positive results from clinical trials for JANX.US's drug candidates usually boost investor optimism and drive the stock price up. Conversely, negative results can cause a decline.

Competition: The presence of competitors and the emergence of competing drugs impact JANX.US's market share and revenue potential, influencing its stock valuation.

Market Sentiment: General investor confidence and risk appetite in the overall stock market can affect demand for JANX.US shares, leading to price fluctuations.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and economic growth can influence overall investment decisions and affect JANX.US's stock price.

News and Events: Company-specific news, such as partnerships, acquisitions, or major product launches, as well as global health events, can lead to volatility in JANX.US's stock price.

Analyst Ratings: Recommendations and price targets from financial analysts can sway investor sentiment and influence buying or selling pressure on JANX.US shares.

Management Decisions: Strategic decisions made by JANX.US's management team, such as investment strategies, acquisitions, or product development plans, can affect investor confidence and the stock price.